glp 1 treatment GLP-1 Therapy GLP-1 Essentials - TRC Healthcare
Description
Weight loss has been long recognized as a disease-modifying therapy in IIH with patients being commonly recommended to lose 10% weight, although the amount of weight loss required to achieve disease remission remains unclear [1]
About 10.3% of patients on the 36 mg dose stopped the drug because of side effects, compared with 2.6% on placebo
Preclinical work also points to applications in reproductive health (e.g., PCOS-related fertility improvements) and oncology, where observational studies link GLP-1 use to lower risks of obesity-related cancers
The initial dosing starts at 0.25 mg per week and is gradually increased at 4-week intervals to 0.5, 1.0, 1.7 mg, and finally to a maximum dose of 2.4 mg per week
It found a substantially increased risk of deep vein thrombosis (DVT) for patients taking semaglutide drugs to treat type 2 diabetes
